Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 14.41
-0.33 (-2.24%)
Jun 10, 2026, 3:00 PM CST
SHA:600521 Market Cap
SHA:600521 has a market cap or net worth of 21.47 billion as of June 10, 2026. Its market cap has increased by 0.77% in one year.
Market Cap
21.47B
Enterprise Value
27.95B
Revenue
8.55B
Ranking
n/a
PE Ratio
80.06
Stock Price
14.41
Market Cap Chart
Since March 4, 2003, SHA:600521's market cap has increased from 3.97B to 21.47B, an increase of 440.80%. That is a compound annual growth rate of 7.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 21.47B | -15.09% |
| Dec 31, 2025 | 25.29B | -2.34% |
| Dec 31, 2024 | 25.89B | 19.93% |
| Dec 29, 2023 | 21.59B | -33.42% |
| Dec 30, 2022 | 32.43B | 0.57% |
| Dec 31, 2021 | 32.25B | -34.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 25.80B |
| Shijiazhuang Yiling Pharmaceutical | 25.73B |
| Livzon Pharmaceutical Group | 24.85B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 23.87B |
| Tasly Pharmaceutical Group | 21.20B |
| Kangmei Pharmaceutical | 20.88B |
| Betta Pharmaceuticals | 20.57B |
| Jilin Aodong Pharmaceutical Group | 19.90B |